Skip to main navigation Skip to search Skip to main content

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

  • Harold J. Burstein
  • , Anthony D. Elias
  • , Hope S. Rugo
  • , Melody A. Cobleigh
  • , Antonio C. Wolff
  • , Peter D. Eisenberg
  • , Mary Lehman
  • , Bonne J. Adams
  • , Carlo L. Bello
  • , Samuel E. DePrimo
  • , Charles M. Baum
  • , Kathy D. Miller

Research output: Contribution to journal › Article › peer-review

444   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science